28.58 F
New York
January 27, 2022

HECA

EU drug regulator OKs Pfizer COVID pill for high-risk patients

Reuters
by Reuters00
Jan 27 (Reuters) – The European Union’s drug regulator on Thursday gave the green light to Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant. The endorsement by the European Medicines Agency......
Read more

As Omicron ebbs, England revives Plan A: living with COVID

Reuters
by Reuters00
Plan B COVID-19 measures expire in England on Thursday Beleaguered PM Johnson bets on boosters and antivirals Omicron’s lower severity and boosters improved outcomes in Jan But experts say endemic COVID may still be common and deadly LONDON, Jan 27 (Reuters) – After an uncomfortable but relatively brief return to......
Read more

Cannabis compound CBD stops coronavirus in test tube, but can it treat COVID?

Reuters
by Reuters00
Jan 25 (Reuters) – Early research suggesting that a popular non-psychoactive compound derived from marijuana might help prevent or treat COVID-19 warrants further investigation in rigorous clinical trials, researchers say. Several recent laboratory studies of cannabidiol, or CBD, have shown promising results, attracting media attention. However, many other potential COVID......
Read more

U.S. business borrowing for equipment fell 3% in December – ELFA

Reuters
by Reuters00
A U.S. one dollar banknote is seen in this illustration taken November 23, 2021. REUTERS/Murad Sezer/Illustration/File Photo Register now for FREE unlimited access to Reuters.com Register Jan 25 (Reuters) – U.S. companies borrowed 3% less in December to finance their investments in equipment, the Equipment Leasing and Finance Association (ELFA)......
Read more

J&J expects COVID vaccine sales to jump as much as 46% in 2022

Reuters
by Reuters00
People pose with syringe with needle in front of displayed Johnson & Johnson logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Jan 25 (Reuters) – Johnson & Johnson (JNJ.N) on Tuesday forecast as much as $3.5 billion in sales......
Read more

After rocky start to year, Unilever axes 1,500 managers

Reuters
by Reuters00
To create five product-focused divisions Long-planned revamp comes after failed bid for GSK unit Comes amid news of stakebuilding by activist investor LONDON, Jan 25 (Reuters) – Unilever (ULVR.L) will cut about 1,500 management jobs and reshape its business to focus on five main product areas as it tries to......
Read more

Britain says 6,000 more people needed for trial of Merck COVID pill

Reuters
by Reuters00
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters on October 26, 2021. Merck & Co Inc/Handout via REUTERS Register now for FREE......
Read more

U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments

Reuters
by Reuters00
Jan 24 (Reuters) – The U.S. health regulator revised on Monday the emergency use authorizations for COVID-19 antibody treatments from Regeneron (REGN.O) and Eli Lilly (LLY.N) to limit their use, as the drugs are unlikely to work against the Omicron coronavirus variant. The Food and Drug Administration (FDA) said the......
Read more

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots – study

Reuters
by Reuters00
Vials of Chinese Sinovac’s CoronaVac vaccine against coronavirus disease (COVID-19) pictured inside the newly inaugurated production lab designated to manufacture the vaccine, in Constantine, Algeria September 29, 2021. REUTERS/Ramzi Boudina Register now for FREE unlimited access to Reuters.com Register Jan 24 (Reuters) – A third booster dose of a COVID-19......
Read more

Do not assume COVID pandemic reaching ‘end game’, warns WHO

Reuters
by Reuters00
Tedros warns against lurching between ‘panic and neglect’ Pandemic in third year, with nearly 6 million dead More variants likely to follow Omicron, WHO warns GENEVA, Jan 24 (Reuters) – The head of the World Health Organization (WHO) warned on Monday that it was dangerous to assume the Omicron variant......
Read more

Nelson Peltz’s Trian builds stake in Unilever – source

Reuters
by Reuters00
Nelson Peltz founding partner of Trian Fund Management LP. speak at the WSJD Live conference in Laguna Beach, California October 25, 2016. REUTERS/Mike Blake Register now for FREE unlimited access to Reuters.com Register Jan 23 (Reuters) – Trian Partners, Nelson Peltz’s activist hedge fund, has built a stake in Unilever......
Read more

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

Reuters
by Reuters00
JERUSALEM, Jan 22 (Reuters) – Pfizer Inc (PFE.N) Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic. Pfizer/BioNtech’s (22UAy.DE) COVID-19 vaccine has shown to be effective against severe disease and death caused by the......
Read more

China’s Beijing to maintain COVID emergency status as Winter Olympics loom

Reuters
by Reuters00
Staff members in protective suits check proof of negative test results for travellers at an entrance to the Harbin West Railway Station following new local cases of the coronavirus disease (COVID-19) in Harbin, Heilongjiang province, China September 22, 2021. cnsphoto via REUTERS Register now for FREE unlimited access to Reuters.com......
Read more

Tokyo hits record 10,000 COVID cases, Japan over 50,000 for first time

Reuters
by Reuters00
TOKYO, Jan 22 (Reuters) – Tokyo recorded its fourth record number of daily COVID-19 infections on Saturday, breaking above 10,000, while Japan’s exceeded 50,000 for the first time as the Omicron variant continues to spread rapidly. The capital had 11,227 new coronavirus cases, the local government said a day after......
Read more

U.S. judge blocks Biden federal employee COVID vaccine mandate

Reuters
by Reuters00
WASHINGTON, Jan 21 (Reuters) – A judge in Texas ruled on Friday that President Joe Biden could not require federal employees to be vaccinated against the coronavirus and blocked the U.S. government from disciplining employees who failed to comply. It was the latest setback to White House efforts to require......
Read more

UK designates Omicron sub-lineage a variant under investigation

Reuters
by Reuters00
LONDON/COPENHAGEN, Jan 21 (Reuters) – The UK Health Security Agency on Friday designated a sub-lineage of the dominant and highly transmissible Omicron coronavirus variant as a variant under investigation, saying it could have a growth advantage. BA.2, which does not have the specific mutation seen with Omicron that can help......
Read more

A divided nation: Western Australia stays shut as COVID deaths mount in east

Reuters
by Reuters00
The words “OMICRON SARS-COV-2” are seen reflected in a drop from a syringe needle in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register SYDNEY, Jan 21 (Reuters) – Australia will remain a divided nation with the vast mining state of Western......
Read more

Analysis: How Omicron highlights fading hope of herd immunity from COVID

Reuters
by Reuters00
CHICAGO, Jan 20 (Reuters) – The Omicron variant, which is spreading far faster than previous versions of the coronavirus, is not likely to help countries achieve so-called herd immunity against COVID-19, in which enough people become immune to the virus that it can no longer spread, leading disease experts say.......
Read more

U.S. to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight

Reuters
by Reuters00
WASHINGTON/LOS ANGELES, Jan 19 (Reuters) – The U.S. government will make 400 million non-surgical “N95” masks from its strategic national stockpile available for free to the public starting next week, a White House official said, as the Biden administration tries to curb the COVID-19 pandemic. Snug-fitting N95 face masks, so-called......
Read more

Djokovic bets on a COVID cure as he quests for tennis history

Reuters
by Reuters00
Serbian tennis player Novak Djokovic arrives at Nikola Tesla Airport, after the Australian Federal Court upheld a government decision to cancel his visa to play in the Australian Open, in Belgrade, Serbia January 17, 2022. REUTERS/Christopher Pike Register now for FREE unlimited access to Reuters.com Register COPENHAGEN, Jan 19 (Reuters)......
Read more

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More